Spain · Delayed Price · Currency is EUR BME:YVIV Statistics
Total Valuation
BME:YVIV has a market cap or net worth of EUR 995.57 million. The enterprise value is 1.73 billion.
| Market Cap | 995.57M |
| Enterprise Value | 1.73B |
Important Dates
The next estimated earnings date is Thursday, April 16, 2026.
| Earnings Date | Apr 16, 2026 |
| Ex-Dividend Date | Jul 16, 2025 |
Share Statistics
BME:YVIV has 732.03 million shares outstanding.
| Current Share Class | 732.03M |
| Shares Outstanding | 732.03M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +2.99% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 11.26.
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | 11.26 |
| Forward PE | n/a |
| PS Ratio | 14.33 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 0.86 |
| P/FCF Ratio | 71.80 |
| P/OCF Ratio | 71.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 40.68, with an EV/FCF ratio of 125.10.
| EV / Earnings | 19.74 |
| EV / Sales | 24.97 |
| EV / EBITDA | 40.68 |
| EV / EBIT | 40.92 |
| EV / FCF | 125.10 |
Financial Position
The company has a current ratio of 0.11, with a Debt / Equity ratio of 0.64.
| Current Ratio | 0.11 |
| Quick Ratio | 0.11 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 17.43 |
| Debt / FCF | 53.58 |
| Interest Coverage | 1.86 |
Financial Efficiency
Return on equity (ROE) is 7.88% and return on invested capital (ROIC) is 1.47%.
| Return on Equity (ROE) | 7.88% |
| Return on Assets (ROA) | 1.42% |
| Return on Invested Capital (ROIC) | 1.47% |
| Return on Capital Employed (ROCE) | 2.24% |
| Revenue Per Employee | 771,678 |
| Profits Per Employee | 976,044 |
| Employee Count | 90 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:YVIV has paid 15.26 million in taxes.
| Income Tax | 15.26M |
| Effective Tax Rate | 14.80% |
Stock Price Statistics
The stock price has increased by +0.74% in the last 52 weeks. The beta is -0.00, so BME:YVIV's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | +0.74% |
| 50-Day Moving Average | 1.37 |
| 200-Day Moving Average | 1.36 |
| Relative Strength Index (RSI) | 17.33 |
| Average Volume (20 Days) | 95 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:YVIV had revenue of EUR 69.45 million and earned 87.84 million in profits. Earnings per share was 0.12.
| Revenue | 69.45M |
| Gross Profit | 62.97M |
| Operating Income | 42.39M |
| Pretax Income | 103.10M |
| Net Income | 87.84M |
| EBITDA | 42.63M |
| EBIT | 42.39M |
| Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 4.03 million in cash and 742.91 million in debt, giving a net cash position of -738.88 million or -1.01 per share.
| Cash & Cash Equivalents | 4.03M |
| Total Debt | 742.91M |
| Net Cash | -738.88M |
| Net Cash Per Share | -1.01 |
| Equity (Book Value) | 1.16B |
| Book Value Per Share | 1.59 |
| Working Capital | -65.64M |
Cash Flow
In the last 12 months, operating cash flow was 13.97 million and capital expenditures -102,000, giving a free cash flow of 13.87 million.
| Operating Cash Flow | 13.97M |
| Capital Expenditures | -102,000 |
| Free Cash Flow | 13.87M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 90.67%, with operating and profit margins of 61.03% and 126.48%.
| Gross Margin | 90.67% |
| Operating Margin | 61.03% |
| Pretax Margin | 148.45% |
| Profit Margin | 126.48% |
| EBITDA Margin | 61.39% |
| EBIT Margin | 61.03% |
| FCF Margin | 19.96% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.49%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.49% |
| Dividend Growth (YoY) | -6.96% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 5.58% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.49% |
| Earnings Yield | 8.82% |
| FCF Yield | 1.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |